NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
3.850
0.00 (0.00%)
At close: Jul 2, 2026, 4:00 PM EDT
3.590
-0.260 (-6.75%)
After-hours: Jul 2, 2026, 6:04 PM EDT
NewcelX Employees
As of December 31, 2025, NewcelX had 12 total employees, including 9 full-time and 3 part-time employees. The number of employees decreased by 3 or -20.00% compared to the previous year.
Employees
12
Change (1Y)
-3
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$691,667
Market Cap
20.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 12 | -3 | -20.00% | 9 | 3 |
| Dec 31, 2024 | 15 | 3 | 25.00% | 11 | 4 |
| Dec 31, 2023 | 12 | -19 | -61.29% | 12 | 0 |
| Dec 31, 2022 | 31 | -1 | -3.13% | 31 | 0 |
| Dec 31, 2020 | 32 | - | - | 28 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Longeveron | 38 |
| Palatin Technologies | 29 |
| SeaStar Medical Holding | 17 |
| Quantum BioPharma | 17 |
| Lipocine | 14 |
| Tvardi Therapeutics | 12 |
| Cellectar Biosciences | 11 |
NCEL News
- 3 days ago - NewcelX completes Type B Pre-IND meeting with FDA for NCEL-101 - TheFly
- 3 days ago - NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes - GlobeNewsWire
- 20 days ago - NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform - GlobeNewsWire
- 5 weeks ago - NewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA - TheFly
- 5 weeks ago - NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes - GlobeNewsWire
- 7 weeks ago - NewcelX files to sell 2.26M common shares for holders - TheFly
- 2 months ago - NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 - GlobeNewsWire
- 2 months ago - NewcelX announces release of updated presentation on Type 1 Diabetes program - TheFly